MARKET

RNLXD

RNLXD

Renalytix Plc
OTCMQB
3.700
+3.541
+2232.91%
Closed 15:58 12/16 EST
OPEN
3.800
PREV CLOSE
0.159
HIGH
3.800
LOW
3.600
VOLUME
748
TURNOVER
2.82K
52 WEEK HIGH
8.00
52 WEEK LOW
3.248
MARKET CAP
32.34M
P/E (TTM)
-0.0113
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at RNLXY last week (1208-1212)?
Weekly Report · 1d ago
Weekly Report: what happened at RNLXY last week (1201-1205)?
Weekly Report · 12/08 10:29
Renalytix Plc Reports Strong Growth and Strategic Partnerships
TipRanks · 12/03 03:50
Weekly Report: what happened at RNLXY last week (1124-1128)?
Weekly Report · 12/01 10:24
Weekly Report: what happened at RNLXY last week (1117-1121)?
Weekly Report · 11/24 10:29
Renalytix Publishes Pivotal KidneyIntelX.dkd Data Demonstrating Improved CKD Risk Prediction
Reuters · 11/18 12:51
Pivotal kidneyintelX.dkd Data Published in Diabetes Care, Considered the Leading Clinical Journal Worldwide in Diabetes
PR Newswire · 11/18 12:51
Weekly Report: what happened at RNLXY last week (1110-1114)?
Weekly Report · 11/17 10:30
More
About RNLXD
Renalytix plc is a United Kingdom-based company, which is engaged in the development of artificial intelligence-enabled clinical diagnostic solutions for kidney disease. The Company is engaged in a field of bioprognosis for kidney health. The Company has engineered a solution that enables early-stage chronic kidney disease progression risk assessment. KidneyIntelX, is a vitro diagnostic platform, employs a proprietary algorithm that combines diverse data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data from electronic health record or EHR, systems, to generate a patient risk score. KidneyIntelX has been granted designation by the United States Food and Drug Administration and is designed to help make significant improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.

Webull offers Renalytix PLC (ADR) stock information, including OTCMQB: RNLXD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RNLXD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RNLXD stock methods without spending real money on the virtual paper trading platform.